Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Clinical trial NCT00176605 · COMPLETED
Trial details
- NCT number
- NCT00176605
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-10-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.